ABVC BioPharma (ABVC) delays BioKey share payout to August 21, 2026
Rhea-AI Filing Summary
ABVC BioPharma, Inc. postponed the previously announced distribution of ordinary shares of BioKey (Cayman), Inc. that had been scheduled for August 3, 2026. The company now expects the distribution to occur on August 21, 2026, after completing additional administrative, regulatory and tax-related steps.
The record date remains July 24, 2026, and shareholders of ABVC common stock as of that date are expected to receive 0.169464 ordinary shares of BioKey for each ABVC share. The earlier ex-dividend date will be replaced, and a new ex-dividend date will be announced once finalized.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
New distribution date: August 21, 2026
Original distribution date: August 3, 2026
Record date: July 24, 2026
+3 more
6 metrics
New distribution date
August 21, 2026
Scheduled date for BioKey (Cayman), Inc. ordinary share distribution
Original distribution date
August 3, 2026
Previously scheduled date before postponement
Record date
July 24, 2026
Shareholders of record on this date eligible for the distribution
Distribution ratio
0.169464 shares
BioKey ordinary shares per ABVC common share held on the record date
Par value of common stock
$0.001 per share
Par value of ABVC common stock listed on Nasdaq
Company phone number
(510) 668-0881
Registrant’s telephone number including area code
Key Terms
record date, ex-dividend date, distribution ratio, ordinary shares, +1 more
5 terms
record date financial
"The previously announced record date of July 24, 2026 remains unchanged"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
ex-dividend date financial
"The previously announced ex-dividend date will no longer apply and will be revised"
The ex-dividend date is the date when a stock starts trading without the value of its next dividend payment included. If you buy the stock on or after this date, you won't receive that upcoming dividend; only those who owned the stock before this date are entitled to it. It matters to investors because it determines who is eligible to receive the dividend and can influence the stock’s price around that time.
distribution ratio financial
"the distribution ratio will remain 0.169464 ordinary shares of BioKey (Cayman), Inc."
transfer agent financial
"the Company’s transfer agent regarding the revised distribution mechanics"
A transfer agent is a financial service that keeps the official record of who owns a company's shares, handles the buying and selling of those shares on paper or electronically, and issues or cancels stock certificates. Think of it as the company’s records keeper and mailroom combined—investors rely on it to make sure dividends, shareholder mailings, ownership changes, and proxy voting are processed accurately and securely, which protects ownership rights and helps prevent errors or fraud.
FAQ
When will ABVC (ABVC) announce the new ex-dividend date for the BioKey distribution?
ABVC explains that the previously announced ex-dividend date no longer applies. The company will announce a new ex-dividend date after finalizing it and completing remaining administrative, regulatory, and tax-related matters.
What coordination did ABVC (ABVC) undertake for the revised BioKey distribution date?
ABVC states it coordinated with The Nasdaq Stock Market LLC, The Depository Trust Company, and its transfer agent to adjust the distribution mechanics and establish the new August 21, 2026 distribution date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
